1. Takanashi J, Barkovich AJ, Shiihara T, Tada H, Kawatani M, Tsukahara H, et al. Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. AJNR Am J Neuroradiol. 2006; 27:836–8.
2. Kim SS, Chang KH, Kim ST, Suh DC, Cheon JE, Jeong SW, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol. 1999; 20:125–9.
3. Gürtler S, Ebner A, Tuxhorn I, Ollech I, Pohlmann-Eden B, Woermann FG. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology. 2005; 65:1032–6.

4. Goenka AH, Mukund A, Ahuja J, Kumar A. Reversible lesion in the splenium of the corpus callosum in a child with influenza-associated encephalitis-encephalopathy (IAEE). J Clin Neurosci. 2010; 17:607, 678.

5. Takanashi J, Barkovich AJ, Yamaguchi K, Kohno Y. Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review. AJNR Am J Neuroradiol. 2004; 25:798–802.
6. Takeuchi S, Takasato Y, Masaoka H, Hayakawa T, Otani N, Yoshino Y, et al. Transient lesion in the splenium of the corpus callosum caused by diffuse axonal injury. Brain Nerve. 2008; 60:1078–9.
7. Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology. 2004; 63:1854–8.

8. Linn FH, Rinkel GJ, Algra A, van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke. 1996; 27:625–9.
9. Miyazaki T, Ohta F, Moritake K, Nagase A, Kagawa T. The key to improving prognosis for aneurysmal subarachnoid hemorrhage remains in the pre-hospitalization period. Surg Neurol. 2006; 65:360–5. discussion 365-6.

10. Sibon I, Menegon P, Rouanet F, Dousset V, Orgogozo JM. MRI of acute brainstem ischaemia: cytotoxic versus vasogenic oedema? Eur J Neurol. 2004; 11:497–8.

11. Busch E, Beaulieu C, de Crespigny A, Moseley ME. Diffusion MR imaging during acute subarachnoid hemorrhage in rats. Stroke. 1998; 29:2155–61.

12. Fried LF, Palevsky PM. Hyponatremia and hypernatremia. Med Clin North Am. 1997; 81:585–609.

13. van Gijn J, Hijdra A, Wijdicks EF, Vermeulen M, van Crevel H. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1985; 63:355–62.
14. Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke. 2009; 40:1963–8.
15. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988; 19:604–7.

16. Garcia-Monco JC, Cortina IE, Ferreira E, Martínez A, Ruiz L, Cabrera A, et al. Reversible splenial lesion syndrome (RESLES): what’s in a name? J Neuroimaging. 2011; 21:e1–14.

17. Gallucci M, Limbucci N, Paonessa A, Caranci F. Reversible focal splenial lesions. Neuroradiology. 2007; 49:541–4.

18. Lin YW, Yu CY. Reversible focal splenium lesion-MRS study of a different etiology. Acta Neurol Taiwan. 2009; 18:203–6.
19. Burg MB. Molecular basis for osmoregulation of organic osmolytes in renal medullary cells. J Exp Zool. 1994; 268:171–5.

20. Conti M, Salis A, Urigo C, Canalis L, Frau S, Canalis GC. Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature. Radiol Med. 2007; 112:921–35.

21. Aboitiz F, Scheibel AB, Fisher RS, Zaidel E. Fiber composition of the human corpus callosum. Brain Res. 1992; 598:143–53.

22. Aboitiz F, Montiel J. One hundred million years of interhemispheric communication: the history of the corpus callosum. Braz J Med Biol Res. 2003; 36:409–20.

23. Chepuri NB, Yen YF, Burdette JH, Li H, Moody DM, Maldjian JA. Diffusion anisotropy in the corpus callosum. AJNR Am J Neuroradiol. 2002; 23:803–8.
24. Whittall KP, MacKay AL, Graeb DA, Nugent RA, Li DK, Paty DW. In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med. 1997; 37:34–43.
25. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci. 2003; 4:991–1001.

26. Makino T, Ito S, Mori M, Yonezu T, Ogawa Y, Kuwabara S. Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica. Mult Scler. 2013; 19:308–15.

27. Güven H, Delibaş S, Comoğlu SS. Transient lesion in the splenium of the corpus callosum due to carbamazepine. Turk Neurosurg. 2008; 18:264–70.
28. Mori H, Maeda M, Takanashi J, Kunimatsu A, Matsushima N, Suzuki H, et al. Reversible splenial lesion in the corpus callosum following rapid withdrawal of carbamazepine after neurosurgical decompression for trigeminal neuralgia. J Clin Neurosci. 2012; 19:1182–4.

29. Narita H, Odawara T, Kawanishi C, Kishida I, Iseki E, Kosaka K. Transient lesion in the splenium of the corpus callosum, possibly due to carbamazepine. Psychiatry Clin Neurosci. 2003; 57:550–1.

30. Nifle C, Couratier M, Jallade C, Sarfati Y, Mignon F, Pico F. Transient high-intensity T2 signal in the splenium of the corpus callosum in a non-epileptic patient. Rev Meurol (Paris). 2007; 163:736–9.
31. Kahilogullari G, Comert A, Ozdemir M, Brohi RA, Ozgural O, Esmer AF, et al. Arterial vascularization patterns of the splenium: an anatomical study. Clin Anat. 2013; 26:675–81.
